Journal Home
Search for

Volume 37, Issue 4, Pages 439-442 (May 2010)


View previous. 8 of 18 View next.

Improved synthesis of 2′-deoxy-2′-[18F]-fluoro-1-β-d-arabinofuranosyl-5-iodouracil ([18F]-FIAU)

Harry Andersona, NagaVaraKishore Pillarsettyb, Melchor Cantoriasb, Jason S. LewisbCorresponding Author Informationemail address

Received 18 September 2009; received in revised form 4 January 2010; accepted 17 January 2010. published online 08 March 2010.

Abstract 

An improved synthesis of 2′-[18F]-fluoro-2′-deoxy-1-β-d-arabinofuranosyl-5-iodouracil ([18F]-FIAU) has been developed. The method utilizes trimethylsilyl trifluoromethanesulfonate (TMSOTf) catalyzed coupling of 2-deoxy-2-[18F]-fluoro-1,3,5-tri-O-benzoyl-d-arabinofuranose with 2,4-bis(trimethylsilyloxy)-5-iodouracil to yield the protected dibenzoyl-[18F]-FIAU. Dibenzoyl-[18F]-FIAU was deprotected with sodium methoxide to yield a mixture of α- and β-anomers in a ratio of 1:1, which were purified by HPLC. The procedure described in this article eliminates the need for HBr activation of the sugar prior to coupling with silylated iodouracil and is suitable for automation. The total reaction time was about 110 min, starting from [18F]-fluoride. The average isolated yield of the required β-anomer was 10±6% (decay corrected) with average specific activity of 125 mCi/μmol.

a Advion BioSystems, 19 Brown Road, Ithaca, NY 14850, USA

b Radiochemistry Service, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA

Corresponding Author InformationCorresponding author. Tel.: +1 646 888 3038; fax: +1 646 422 0408.

PII: S0969-8051(10)00022-3

doi:10.1016/j.nucmedbio.2010.01.003


View previous. 8 of 18 View next.